This market research report details the segmentation of the global orthobiologics market by product type (stem cells, bone morphogenetic proteins, synthetic bone grafts, viscosupplements, demineralized bone matrix, and allografts) and by procedure (spinal fusion and orthopedic trauma and reconstruction). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are DePuy Synthes, Medtronic, Sanofi, Stryker, Zimmer-Biomet.
Technavio’s market research analysts estimate the global orthobiologics market, to grow at a CAGR of 7% between 2016 and 2020. Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Recent developments in orthobiologics are the launch of bone grafts and tissue regeneration products that accelerate the bone healing process. The Americas is the largest market in orthobiologics, occupying around 60% of the overall market share. The rising demand for these products to treat various orthopedic indications such as spinal injuries and osteoarthritis is the primary reason for the growth of the market in this region.
The new market research report from Technavio provides a breakdown and analysis of the orthobiologics segments by technology.
“Of late, the market is witnessing increase in funds to enhance orthobiologics. Vendors in the market are extensively investing in research to develop a wide range of innovative products, strengthening their portfolio and successful commercialization of products. Such developments will lead to the growth of the orthobiologics market over the next five years,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research
More than half of the market share is occupied by the spinal fusion surgery segment, as this type of surgery is considered the golden standard for the treatment of spinal degenerative diseases. With each year, a number of medical facilities is using spinal fusion surgery to treat the condition. Moreover, manufacturers are taking initiatives to spread knowledge of the surgery that use minimally invasive procedures to treat spinal degenerative diseases.
Global orthobiologics market by procedure
Source: Technavio, 2016
The leading vendors in the global orthobiologics market are DePuy Synthes, Medtronic, Sanofi, Stryker, Zimmer-Biomet. The market marks the dominance of the major players who compete on the basis of technological innovation and consumer services. Since the competition in the market is vigorous, both global and local players are developing new technologies and products such as stem cells and synthetic bone graft, which do not cause infection and can help in regeneration at a faster rate to sustain in the market.
A more detailed analysis is available in the Technavio report, Global Orthobiologics Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
